Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Newamsterdam Pharma Company ORDINARY SHARES | 12,131,705 | 12,226,943 | +95,238 | $135.51M | $289.17M | 12.20% | +$153.66M |
| Krystal Biotech, Inc.(KRYS) | 988,460 | 988,460 | 0 | $122.63M | $175.88M | 7.42% | +$53.25M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 6,495,392 | 6,495,392 | 0 | $191.74M | $163.16M | 6.88% | -$28.58M |
| Hillevax Inc | 9,781,472 | 9,781,472 | 0 | $156.99M | $162.67M | 6.86% | +$5.67M |
| Alpine Immune Sciences Inc | 3,131,008 | 3,131,008 | 0 | $59.68M | $124.11M | 5.24% | +$64.44M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 10,109,279 | 10,109,279 | 0 | $92.30M | $107.36M | 4.53% | +$15.06M |
| BridgeBio Pharma, Inc.(BBIO) | 2,725,949 | 3,415,604 | +689,655 | $110.05M | $105.61M | 4.46% | -$4.44M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 2,371,304 | 2,190,179 | -181,125 | $109.01M | $94.90M | 4.00% | -$14.11M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 8,764,232 | 8,785,284 | +21,052 | $28.31M | $87.06M | 3.67% | +$58.75M |
| Vaxcyte, Inc.(PCVX) | 1,164,405 | 1,139,405 | -25,000 | $73.12M | $77.83M | 3.28% | +$4.71M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 1,787,527 | 1,787,527 | 0 | $36.20M | $64.98M | 2.74% | +$28.78M |
| Edgewise Therapeutics, Inc.(EWTX) | 2,667,203 | 3,303,567 | +636,364 | $29.18M | $60.26M | 2.54% | +$31.08M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 2,142,855 | 4,142,855 | +2,000,000 | $19.71M | $56.96M | 2.40% | +$37.25M |
| Apellis Pharmaceuticals Inc COM | 885,165 | 885,165 | 0 | $52.99M | $52.03M | 2.20% | -$956.0K |
| Disc Medicine, Inc.(IRON) | 785,000 | 785,000 | 0 | $45.34M | $48.87M | 2.06% | +$3.53M |
| Verona Pharma PlcADS | 3,014,349 | 3,014,349 | 0 | $59.93M | $48.50M | 2.05% | -$11.42M |
| Kalvista Pharmaceuticals Inc | 3,622,294 | 3,687,867 | +65,573 | $44.37M | $43.74M | 1.85% | -$635.0K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,523,013 | 1,561,230 | +38,217 | $45.64M | $42.06M | 1.77% | -$3.59M |
| Soleno Therapeutics Inc | 464,937 | 875,667 | +410,730 | $18.71M | $37.48M | 1.58% | +$18.76M |
| MacroGenics, Inc.(MGNX) | 2,401,704 | 2,471,704 | +70,000 | $23.10M | $36.38M | 1.54% | +$13.28M |
| Aerovate Therapeutics Inc | 1,204,867 | 1,204,867 | 0 | $27.27M | $35.63M | 1.50% | +$8.36M |
| CG Oncology, Inc.(CGON) | 0 | 770,000 | +770,000 | $0 | $33.80M | 1.43% | +$33.80M |
| Merus N V | 746,479 | 746,479 | 0 | $20.53M | $33.61M | 1.42% | +$13.09M |
| Revolution Medicines, Inc.(RVMD) | 997,455 | 997,455 | 0 | $28.61M | $32.15M | 1.36% | +$3.54M |
| Autolus Therapeutics plcADS(AUTL) | 3,746,857 | 4,623,324 | +876,467 | $24.13M | $29.50M | 1.24% | +$5.37M |
| Structure Therapeutics IncADS | 317,190 | 629,194 | +312,004 | $12.93M | $26.97M | 1.14% | +$14.04M |
| Trevi Therapeutics, Inc.(TRVI) | 7,381,090 | 7,381,090 | 0 | $9.89M | $25.46M | 1.07% | +$15.57M |
| Silence Therapeutics plcADS(SLN) | 881,173 | 1,148,591 | +267,418 | $15.31M | $24.81M | 1.05% | +$9.50M |
| Deciphera Pharmaceuticals In | 1,021,800 | 1,455,837 | +434,037 | $16.48M | $22.90M | 0.97% | +$6.42M |
| PepGen Inc.(PEPG) | 0 | 1,502,788 | +1,502,788 | $0 | $22.09M | 0.93% | +$22.09M |
| Anaptysbio Inc | 899,700 | 899,700 | 0 | $19.27M | $20.26M | 0.85% | +$989.7K |
| Savara Inc.(SVRA) | 4,000,000 | 4,000,000 | 0 | $18.80M | $19.92M | 0.84% | +$1.12M |
| Cerevel Therapeutics Hldng I | 393,000 | 393,000 | 0 | $16.66M | $16.61M | 0.70% | -$51.1K |
| Agios Pharmaceuticals, Inc.(AGIO) | 523,166 | 523,166 | 0 | $11.65M | $15.30M | 0.65% | +$3.65M |
| Adverum Biotechnologies Inc | 0 | 1,069,244 | +1,069,244 | $0 | $15.12M | 0.64% | +$15.12M |
| Puma Biotechnology, Inc.(PBYI) | 0 | 2,816,294 | +2,816,294 | $0 | $14.93M | 0.63% | +$14.93M |
| Tyra Biosciences, Inc.(TYRA) | 1,026,420 | 832,220 | -194,200 | $14.22M | $13.65M | 0.58% | -$567.5K |
| Applied Therapeutics Inc | 0 | 1,952,857 | +1,952,857 | $0 | $13.28M | 0.56% | +$13.28M |
| Allogene Therapeutics Inc | 0 | 2,867,750 | +2,867,750 | $0 | $12.82M | 0.54% | +$12.82M |
| Arvinas, Inc.(ARVN) | 285,331 | 285,331 | 0 | $11.74M | $11.78M | 0.50% | +$34.2K |
| 89bio Inc | 2,000,000 | 1,000,000 | -1,000,000 | $22.34M | $11.64M | 0.49% | -$10.70M |
| Acadia Pharmaceuticals Inc | 730,917 | 470,338 | -260,579 | $22.89M | $8.70M | 0.37% | -$14.19M |
| Cogent Biosciences, Inc.(COGT) | 1,995,267 | 936,576 | -1,058,691 | $11.73M | $6.29M | 0.27% | -$5.44M |
| Intellia Therapeutics, Inc.(NTLA) | 203,684 | 203,684 | 0 | $6.21M | $5.60M | 0.24% | -$607.0K |
| Newamsterdam Pharma CompanyW EXP 11 22 202 *W EXP 99/99/999 | 500,333 | 500,333 | 0 | $1.57M | $5.52M | 0.23% | +$3.96M |
| An2 Therapeutics Inc | 1,388,889 | 1,388,889 | 0 | $28.46M | $4.51M | 0.19% | -$23.94M |
| Metagenomi Therapeutics, Inc.(MGX) | 0 | 279,025 | +279,025 | $0 | $2.94M | 0.12% | +$2.94M |
| Gritstone Bio Inc | 1,030,878 | 1,030,878 | 0 | $2.10M | $2.65M | 0.11% | +$546.4K |
| Bluebird Bio Inc | 1,709,907 | 1,709,907 | 0 | $2.36M | $2.19M | 0.09% | -$171.0K |
| Aclaris Therapeutics, Inc.(ACRS) | 264,377 | 264,377 | 0 | $277.6K | $327.8K | 0.01% | +$50.2K |
| Apogee Therapeutics Inc | 400,000 | 0 | -400,000 | $11.18M | $0 | — | -$11.18M |
| Crinetics Pharmaceuticals In | 397,483 | 0 | -397,483 | $14.14M | $0 | — | -$14.14M |
| Dyne Therapeutics, Inc.(DYN) | 1,184,840 | 0 | -1,184,840 | $15.76M | $0 | — | -$15.76M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 69,406 | 0 | -69,406 | $16.06M | $0 | — | -$16.06M |
| Mirati Therapeutics Inc | 80,000 | 0 | -80,000 | $4.70M | $0 | — | -$4.70M |
| Theseus Pharmaceuticals Inc | 2,118,051 | 0 | -2,118,051 | $8.58M | $0 | — | -$8.58M |